Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination ...
Apr 3, 2013
1
0
Researchers at the University of North Carolina School of Medicine and the National Institutes of Health (NIH) have perfected a noninvasive "chemogenetic" technique that allows them to switch off a specific behavior in mice ...
Apr 30, 2015
2
163
About 50 to 60 percent of patients with melanoma have a mutation in the BRAF gene that drives the growth of their cancer. Most of these patients respond well to two novel agents being studied in clinical trials that inhibit ...
Aug 2, 2011
0
0
Scientists from the University of Leeds have found that the protein called prion helps our brains to absorb zinc, which is believed to be crucial to our ability to learn and the wellbeing of our memory.
Oct 16, 2012
0
0
NeuroOmics technology lets researchers label and capture cell-surface proteins in intact, live tissue—opening opportunities to understand complex cellular interactions and future drug targets.
Oct 19, 2022
0
82
A new study reveals details about the evolutionary contest between HIV and the human immune system that could one day improve treatment.
Mar 4, 2019
0
50
Keck Medicine of the University of Southern California (USC) scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface ...
Feb 20, 2015
0
60
The discovery of insulin in the 1920s marked the breakthrough in the almost 3,500-year-long mystery of diabetes, a disease first described in ancient Egyptian papyruses. Until its discovery, physicians struggled to explain ...
Apr 4, 2019
1
147
The stiffness of breast tissue is increasingly recognized as an important factor explaining the onset of breast cancer. Stiffening induces molecular changes that promote cancerous behavior in cells. Bioengineering studies ...
Sep 7, 2012
0
0
In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.
Mar 18, 2021
0
42
